公司資料
Coya Therapeutics 股價、新聞與催化劑
- 股票代碼:
- COYA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
4.96 USD (+1.85%)
收盤價
最後更新: 2026年8月24日
111M USD
市值
股價為何變動
As of Aug 24, 2026, COYA closed up 1.85% at $4.96. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Coya Therapeutics is a biotechnology company focused on immunomodulation and neurodegenerative disease, especially ALS and related conditions. Its story centers on modulating immune pathways to potentially slow neurodegeneration.
所在地與產業分類
Coya is headquartered in the United States and listed on NASDAQ. It sits in neuroscience and immunology biotechnology.
商業模式特徵
The company depends on clinical data, translational validation, and capital support while developing a narrow pipeline. Investors watch early efficacy signals and whether the biology can support a differentiated CNS thesis.
生技產業定位
Coya occupies a specialized immunology-neuroscience niche within biotech. The stock is catalyst-sensitive because it is still proving whether the platform can matter in neurodegeneration.
未來催化劑
- Coya’s catalysts are its immunomodulation and neuroinflammation programs, where the next clinical update can change how investors view the company. The company remains early and data-dependent.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。